Works matching IS 02683369 AND DT 2009 AND VI 43 AND IP 9

Results: 11

Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 9, p. 709, doi. 10.1038/bmt.2008.375

By:

Malladi, R. K.;
Peniket, A. J.;
Littlewood, T. J.;
Towlson, K. E.;
Pearce, R.;
Yin, J.;
Cavenagh, J. D.;
Craddock, C.;
Orchard, K. H.;
Olavarria, E.;
McQuaker, G.;
Collin, M.;
Marks, D. I.

Publication type:

Article

Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 9, p. 685, doi. 10.1038/bmt.2008.376

By:

Saliba, R. M.;
Komanduri, K. V.;
Giralt, S.;
de Souza, J.;
Patah, P.;
Oran, B.;
Couriel, D.;
Rondon, G.;
Champlin, R. E.;
de Lima, M.

Publication type:

Article

Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 9, p. 717, doi. 10.1038/bmt.2008.377

By:

Schleuning, M.;
Judith, D.;
Jedlickova, Z.;
Stübig, T.;
Heshmat, M.;
Baurmann, H.;
Schwerdtfeger, R.

Publication type:

Article

HLA-E upregulation on IFN-γ-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 9, p. 693, doi. 10.1038/bmt.2008.380

By:

Nguyen, S.;
Beziat, V.;
Dhedin, N.;
Kuentz, M.;
Vernant, J. P.;
Debre, P.;
Vieillard, V.

Publication type:

Article

Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome.

Published in:

2009

By:

Ohwada, C.;
Nakaseko, C.;
Sakai, S.;
Takeda, Y.;
Abe, D.;
Takeuchi, M.;
Sakaida, E.;
Masuda, S.;
Shimizu, N.;
Cho, R.;
Nishimura, M.;
Kanai, K.;
Misawa, S.;
Kuwabara, S.

Publication type:

Letter

Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 9, p. 701, doi. 10.1038/bmt.2008.382

By:

Hicks, L. K.;
Woods, A.;
Buckstein, R.;
Mangel, J.;
Pennell, N.;
Zhang, L.;
Imrie, K.;
Spaner, D.;
Cheung, M. C.;
Boudreau, A.;
Reis, M.;
Crump, M.;
Berinstein, N. L.

Publication type:

Article

Strongyloides stercoralis hyperinfection after allogeneic stem cell transplantation.

Published in:

2009

By:

Dulley, F. L.;
Costa, S.;
Cosentino, R.;
Gamba, C.;
Saboya, R.

Publication type:

Letter

Delay in B-lymphocyte recovery and function following rituximab for EBV-associated lymphoproliferative disease early post-allogeneic hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 9, p. 679, doi. 10.1038/bmt.2008.385

By:

Masjosthusmann, K.;
Ehlert, K.;
Eing, B. R.;
Roth, J.;
Koehler, G.;
Juergens, H.;
Fruehwald, M;
Groll, A. H.

Publication type:

Article

A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 9, p. 725, doi. 10.1038/bmt.2009.27

By:

Jarden, M.;
Baadsgaard, M. T.;
Hovgaard, D. J.;
Boesen, E.;
Adamsen, L.

Publication type:

Article

Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 9, p. 669, doi. 10.1038/bmt.2009.59

By:

Kobbe, G.;
Bruns, I.;
Fenk, R.;
Czibere, A.;
Haas, R.

Publication type:

Article

Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants?

Published in:

2009

By:

Gale, R P;
Eapen, M;
Logan, B;
Zhang, M-J;
Lazarus, H M

Publication type:

Correction Notice